Recent years have witnessed remarkable advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as promising https://ronaldbfdq623093.webbuzzfeed.com/39358214/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide